IP Library Granted Patent US 12,460,246
Granted Patent B2
US 12,460,246 · App. 17/416,928 · Granted Nov 4, 2025

DNA-barcoded nucleosomes for chromatin mapping assays

Inventors: Martis W. Cowles (Chapel Hill, NC); Zu-Wen Sun (Brentwood, TN); Michael-Christopher Keogh (Cambridge, MA); Bryan Jacob Venters (Cary, NC); Ellen Nichole Weinzapfel (Durham, NC)
Assignee: EPICYPHER, INC.
C12Q1/6806G01N33/6875
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,460,246
App. No.
17/416,928
Granted
Nov 4, 2025
Kind
B2
Abstract

The present invention relates to DNA-barcoded recombinant nucleosomes and polynucleosomes that have been engineered for use as spike-in controls for chromatin accessibility assays, chromatin mapping assays, e.g., using tethered enzymes, as well as other chromatin assays. The invention further relates to methods of using the engineered DNA-barcoded recombinant nucleosomes in chromatin accessibility assays, chromatin mapping assays, as well as other chromatin assays.

Claims (21)

1 . A nucleosome comprising: a. a protein octamer, containing two copies each of histones H2A, H2B, H3, and H4, and optionally, linker histone H1; b. a DNA molecule, comprising: i. a nucleosome positioning sequence, ii a synthetic DNA barcode indicative of the identity and/or concentration of a nucleosome feature; and iii. one or more linkers, wherein the one or more linkers comprises a nuclease and/or transposase recognition sequence; and c. a binding member linked to the DNA molecule, wherein the binding member is one half of a binding pair; wherein the nucleosome feature is none, one, or more of the histones comprising a post-translational modification or a mutation and/or a histone variant and/or the DNA molecule comprising a post-transcriptional modification wherein at least one of the one or more linkers is between the nucleosome positioning sequence and the binding member; and wherein the nucleosome is a spike-in control for a chromatin assay.

2 . The nucleosome of claim 1 , wherein said linker is 10 to 80 nucleotides in length.

3 . The nucleosome of claim 1 , wherein the nuclease or transposase recognition sequence is recognized by an endodeoxyribonuclease.

4 . The nucleosome of claim 3 , wherein the endodeoxyribonuclease is micrococcal nuclease, Si nuclease, mung bean nuclease, pancreatic DNase I, yeast HO or I-Scel endonuclease, a restriction endonuclease, or a homing endonuclease.

5 . The nucleosome of claim 1 , wherein the nuclease or transposase recognition sequence is recognized by a transposase.

6 . The nucleosome of claim 5 , wherein the transposase is Tn5, Mu, IS5, IS91, Tn552, Tyl, Tn7, Tn/O, Mariner, P Element, Tn3, Tn10, or Tn903.

7 . The nucleosome of claim 1 , wherein the binding member and its binding partner are biotin with avidin or streptavidin, a nano-tag with streptavidin, glutathione with glutathione transferase, an antigen/epitope with an antibody, polyhistidine with nickel, a polynucleotide with a complementary polynucleotide, an aptamer with its specific target molecule, or Si-tag and silica.

8 . The nucleosome of claim 1 , wherein the binding member is linked to the 5′ end of the DNA molecule.

9 . The nucleosome of claim 1 , wherein the binding member is linked to the 3′ end of the DNA molecule.

10 . The nucleosome of claim 1 , wherein the synthetic DNA barcode has a length of 6 to 50 base-pairs.

11 . The nucleosome of claim 1 , wherein each histone in the nucleosome is independently fully synthetic, semi-synthetic, or recombinant.

12 . The nucleosome of claim 1 , wherein the histone post-translational modifications are N-acetylation of serine and alanine; phosphorylation of serine, threonine and tyrosine; N-crotonylation, N-acylation of lysine; N6-methylation, N6, N6-dimethylation, N6, N6, N6-trimethylation of lysine; omega-N-methylation, symmetrical-dimethylation, asymmetrical-dimethylation of arginine; citrullination of arginine; ubiquitinylation of lysine; sumoylation of lysine; O-methylation of serine and threonine, ADP-ribosylation of arginine, aspartic acid and glutamic acid, or any combination thereof.

13 . The nucleosome of claim 1 , wherein the histone variants are H3.3, H2A.Bbd, H2A.Z.1, H2A.Z.2, H2A.X, mH2A1.1, mH2A1.2, mH2A2, TH2B, or any combination thereof.

14 . The nucleosome of claim 1 , wherein the DNA post-transcriptional modifications are 5-methylcytosine, 5-hydroxymethylcytosine, 5-formylcytosine, 5-carboxylcytosine, 3-methylcytosine, or any combination thereof.

15 . A panel of the nucleosomes of claim 1 , wherein the panel comprises at least two nucleosomes comprising different nucleosome features.

16 . The panel of claim 15 , wherein each nucleosome comprising a different nucleosome feature is present at the same concentration in the panel.

17 . The panel of claim 15 , wherein each nucleosome comprising a different nucleosome feature is present at multiple concentrations in the panel and the synthetic DNA barcode of each nucleosome indicates the concentration at which the nucleosome is present in the panel.

18 . The panel of claim 15 , further comprising a nucleosome which does not comprise a nucleosome feature.

19 . A bead comprising a binding partner to the binding member of the nucleosome of claim 1 , wherein the bead is bound to the nucleosome.

20 . A kit comprising the nucleosome of claim 1 .

21 . The nucleosome of claim 1 , wherein the one or more linkers are at the 5′ and/or 3′ end of the DNA molecule.

Assignments (2)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 22, 2025
From: EPICYPHER, INC.
To: BROADOAK FUND VI, L.P.
Reel/Frame 074020/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2021
From: COWLES, MARTIS W.; SUN, ZU-WEN; KEOGH, MICHAEL-CHRISTOPHER; VENTERS, BRYAN JACOB; WEINZAPFEL, ELLEN NICHOLE
To: EPICYPHER, INC.
Reel/Frame 057366/0477 →
Continuity (2)
Provisional Application 62783861 · Dec 21, 2018
Related Publication 20220042074A1 · Feb 10, 2022
References Cited (34)
US 20150197801A1 · Muir et al. · 2015 [cited by applicant]
US 20180217161A1 · Khoja et al. · 2018 [cited by applicant]
JP 2015521462A · 2015 [cited by applicant]
JP 2017506073A · 2017 [cited by applicant]
WO 2013184930A2 · 2013 [cited by applicant]
WO 2014205296A1 · 2014 [cited by applicant]
WO 2015117145A1 · 2015 [cited by applicant]
WO 2017147279A1 · 2017 [cited by applicant]
Zhou et al (2015, Date Published: Aug. 20, 2015, Molecular Cell, cited on attached Form PTO-892; herein referred to as Zhou) ( Year: 2015). [cited by examiner]
Cutter et al. (2015. Date Available Online: May 14, 2015, FEBS Letters, cited on attached Form PTO-892; herein referred to as Cutter). (Year: 2015). [cited by examiner]
Baller et al. (2012, Date Published: 2012, Research, http://www.genome.org/cgi/doi/10.1101/gr.129585.111) {herein Baller}. (Year: 2012). [cited by examiner]
Heinkoff et al. (2010, Date Published: Apr. 2010, Reviews, www.nature.com/reviews/molcellbio) {herein Heinkoff}. ( Year: 2010). [cited by examiner]
Jiang et al (2009, Published Mar. 2009, Reviews, www.nature.com/reviews/genetics) {herein Jiang}. (Year: 2009). [cited by examiner]
Nguyen et al (2014, Date Available: Aug. 2014, HHS Public Access, doi: 10.1038/nmeth.3022) {herein Nguyen}. ( Year: 2014). [cited by examiner]
Sato et al (2019, Date Accepted: Jul. 22, 2019, Open Biology, royalsocietypublishing.org/journal/rsob) {herein Sato}. (Year: 2019). [cited by examiner]
Huang et al (2013, Date Published: Oct. 7, 2013, Biosci. Biotechnol. Biochem, http://dx.doi.org/10.1271/bbb.130399) {herein Huang}. (Year: 2013). [cited by examiner]
K Singh, Raushan, et al. “Protein engineering approaches in the post-genomic era.” Current Protein and Peptide Science 19.1 ( 2018): 5-15. (Year: 2018). [cited by examiner]
Zhang, Meiling, David A. Case, and Jeffrey W. Peng. “Propagated perturbations from a peripheral mutation show interactions supporting WW domain thermostability.” Structure 26.11 (2018): 1474-1485. (Year: 2018). [cited by examiner]
Biotin (2025, Gene Link) {herein Biotin}. (Year: 2025). [cited by examiner]
Liszczak et al (First Published: Aug. 28, 2018, DNA Nanotechnology) {herein Liszczak} (Year: 2018). [cited by examiner]
Lai et al (Date Published: Sep. 2017, Nat Rev Mol Cell Biol.) (Year: 2017). [cited by examiner]
Shaytan et al (Date Available Online: Feb. 27, 2015, Current Opinion in Structural Biology) (Year: 2015). [cited by examiner]
Clark et al (Date Published: Jun. 2010, NIH Public Access) {herein Clark) (Year: 2010). [cited by examiner]
Nguyen et al (2014, Date Available: Aug. 2014, HHS Public Access, doi: 10.1038/nmeth.3022, cited on PTO-892 mailed Sep. 17, 2024) {herein Nguyen} (Year: 2014). [cited by examiner]
Skene, Peter J, et al., “An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites”, eLife, 6:e21856, Jan. 16, 2017. [cited by applicant]
“International Preliminary Report on Patentability corresponding to International Application No. PCT/2019/067735 mailed mailed Jul. 1, 2021”. [cited by applicant]
“International Search Report and Written Opinion corresponding to International Application No. PCT/2019/067735 mailed Apr. 24, 2020”. [cited by applicant]
Bednar, Jan , et al., “Structure and Dynamics of a 197 bp Nucleosome in Complex with Linker Histone H1”, Molecular Cell 66(3):384-397 (May 4, 2017). [cited by applicant]
Voong, Lilien N, et al., “Genome-wide Mapping of the Nucleosome Landscape by Micrococcal Nuclease and Chemical Mapping”, Trends in Genetics 33(8):496-507 (Aug. 2017). [cited by applicant]
“Extended European Search Report corresponding to European Application No. 19898873.5 dated Sep. 8, 2022”. [cited by applicant]
Grzybowski, Adrian T, et al., “Calibrating ChIP-Seq with Nucleosomal Internal Standards to Measure Histone Modification Density Genome Wide”, Molecular Cell 58(5):886-899 (Jun. 4, 2015). [cited by applicant]
Koshisakabe, Mitsunaga , “Mechiruka DNA wo .fukumu Nukureosomu no Kozoseibutsugakutekibunseki”, Kakyuuhi Detabesu 2017, 1-5. [cited by applicant]
Skene, Peter J, et al., “Targeted in situ genome-wide profiling with high efficiency for low cell numbers”, Nat Protoc. 13(5):1006-1019 (Apr. 12, 2018). [cited by applicant]
Linheiro, et al., “Testing the palindromic target site model for DNA transposon insertion using the [cited by applicant]